Rituximab (anti-CD20) HY-P9913A from MedChemExpress | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
MedChemExpress for
Rituximab (anti-CD20)

Description

Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer

Product Specs
ItemRituximab (anti-CD20)
CompanyMedChemExpress
Price $280.00Supplier Page View Company Product Page
Catalog NumberHY-P9913A
Purity99.10%
Research AreaInflammation/Immunology; Cancer
TypeChemical
Molecular Weight144544.44
Quantity1 mg
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Molecule NameRituximab (anti-CD20)

Add to Compare List

MedChemExpress

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) In vitro effects of rituximab on the proliferation, activation and differentiation of human B cellsAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsFebruary 1, 2012Kamburova EG, Koenen HJ, Boon L, Hilbrands LB, Joosten I.

(2) In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomasBloodFebruary 1, 2003Manches O, Lui G, Chaperot L, Gressin R, Molens JP, Jacob MC, Sotto JJ, Leroux D, Bensa JC, Plumas J.

(3) The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis inductionBloodFebruary 1, 2002Byrd JC, Kitada S, Flinn IW, Aron JL, Pearson M, Lucas D, Reed JC.

Be the First to Write a Review!